A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)

Addictive Behaviors

Volumn 31, Issue 3, 2006, Pages 371-387

  Shanahan, M D ^a   Doran, C M ^a,b   Digiusto, E ^a   Bell, J ^c   Lintzeris, N ^a,d,g   White, J ^e,f   Ali, R ^a,e,f   Saunders, J B ^b   Mattick, R P ^a   Gilmour, S ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c South Eastern Sydney Local Health District   (Australia)

^d TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f Drug & Alcohol Services South Australia   (Australia)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Buprenorphine; Cost effectiveness analysis; Detoxification; Heroin; Naltrexone; NEPOD

Indexed keywords

BUPRENORPHINE; CLONIDINE; DIAMORPHINE; METHADONE; NALOXONE; NALTREXONE; OPIATE;

ADULT; ANESTHESIA; ARTICLE; AUSTRALIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG WITHDRAWAL; FEMALE; HEROIN DEPENDENCE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIOID DEPENDENCE; OUTCOME ASSESSMENT; OUTPATIENT; SEDATION; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADULT; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; BUPRENORPHINE; CHI-SQUARE DISTRIBUTION; COST-BENEFIT ANALYSIS; FEMALE; HEROIN DEPENDENCE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; METHADONE; NALTREXONE; NARCOTIC ANTAGONISTS;

EID: 33344458941     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2005.05.016     Document Type: Article

References (39)

1. A. Albanese, C. Gevirtz, B. Oppenheim, J. Field, I. Abels, and J. Eustace Outcome and six-month follow up of patients after ultra rapid opiate detoxification Journal of Addictive Diseases 19 2000 11 28
2. C.J. Bradley, M.T. French, and J.V. Rachal Financing and cost of standard and enhanced methadone treatment Journal of Substance Abuse Treatment 11 5 1994 433 442
3. A. Briggs Handling uncertainty in economic evaluation and presenting the results M.F. Drummond A. McGuire Economic evaluation in health care: Merging theory with practice 2001 Oxford University Press New York
4. W.S. Cartwright Cost-benefit analysis of drug treatment services: review of the literature The Journal of Mental Health Policy and Economics 3 2000 11 26
5. M.A. Chutuape, D.R. Jasinski, M.I. Fingerhood, and M.L. Stitzer One-, three-, and six-month outcomes after brief inpatient opioid detoxification American Journal of Drug and Alcohol Abuse 27 2001 19 44
6. Commonwealth Department of Health and Family Services Medicare benefits schedule book 2001 Australian Government Publishing Service Canberra
7. Commonwealth Department of Health and Family Services Schedule of pharmaceutical benefits 2001 Australian Government Publishing Service Canberra
8. S. Darke Self-report among injecting drug users: A review Drug and Alcohol Dependence 51 1998 253 263
9. E. Digiusto, N. Lintzeris, C. Breen, C. Kimber, R. Mattick, and J. Bell Short-term outcomes of five heroin detoxification methods in the Australian NEPOD project Addictive Behaviors 30 2005 443 456
10. E. Digiusto, V. Seres, A. Bibby, and R. Batey Concordance between urinalysis results and self-reported drug use by applicants for methadone maintenance in Australia Addictive Behaviors 21 3 1996 319 329
11. C. Doran, M. Shanahan, J. Bell, and A. Knowles A cost-effectiveness analysis of buprenorphine assisted heroin withdrawal Drug and Alcohol Review 23 2004 171 175
12. M. Drummond, B. O'Brien, G. Stoddart, and G. Torrance Methods for the economic evaluation of health care programmes 2nd ed. 1997 Oxford University Press Oxford
13. B. Efron, and R. Tibshirani An introduction to the bootstrap Monographs on statistics and applied probability vol. 57 1993 Chapman and Hall New York
14. J. Foster, C. Brewer, and T. Steele Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels Addiction Biology 8 2003 211 217
15. M. Gerra, A. Zaimovic, M. Rustichelli, M. Fontanesi, U. Zambelli, and M. Timpano Rapid opiate detoxification in outpatient treatment. Relationship with naltrexone compliance Journal of Substance Abuse Treatment 18 2000 185 191
16. A. Gibson, C. Doran, J. Bell, A. Ryan, and N. Lintzeris A comparison of buprenorphine treatment in clinic and primary care settings Medical Journal of Australia 179 2003 38 42
17. M. Gold, J. Siegel, L. Russell, and M.C. Weinstein Cost-effectiveness in health and medicine 1996 Oxford University Press New York
18. A.C. Goodman, H.D. Holder, E. Nishiuri, and R.J. Hankin An analysis of short-term alcoholism treatment cost functions Medical Care 30 9 1992 795 810
19. A.C. Goodman, E. Nishiura, and R.S. Humphreys Cost and usage impacts of treatment initiation: A comparison of alcoholism and drug abuse treatments Alcoholism, Clinical and Experimental Research 21 5 1997 931 938
20. M. Gossop, and J. Strang Price, cost and value of opiate detoxification treatments: Reanalysis of data from two randomised trials The British Journal of Psychiatry 177 2000 166 262
21. L. Gowing, R. Ali, and J. White Buprenorphine for the management of opiod withdrawal 2000 Update Software Oxford Vol. Issue 4
22. L. Gowing, R. Ali, and J. White Opioid antagonists and adrenergic agonists for the management fo opioid withdrawal 2000 Update Software Oxford Vol. Issue 2
23. D.T. Hartz, P. Meek, N.A. Piotrowski, D.J. Tusel, C.J. Henke, and K. Delucchi A cost-effective and cost-benefit analysis of contingency contracting-enhanced methadone detoxification treatment American Journal of Drug and Alcohol Abuse 25 2 1999 207 218
24. H.J. Harwood, D. Malhotra, C. Villarivera, C. Liu, U. Chong, and J. Gilani Cost effectiveness and cost benefit analysis of substance abuse treatment: An annotated bibliography 2002 Centre for Substance Abuse Treatment Falls Church Va
25. M.E. Hilton, S.A. Maisto, J. Conigliaro, M. McNiel, K. Kraemer, and M.E. Kelley Improving alcoholism treatment across the spectrum of services Alcoholism, Clinical and Experimental Research 25 1 2001 128 135
26. G. Hulse, and G. O'Neil Using naltrexone implants in the management of the pregnant heroin user Australian and New Zealand Journal of Obstetrics and Gynaecology 42 2002 569 573
27. G.K. Hulse, G. O'Neil, M. Hatton, and M.J. Paech Use of oral and implantable naltrexone in the management of the opioid impaired physician Academic Emergency Medicine 9 2003 196 201
28. L. Janiri, P. Mannelli, A.M. Persico, A. Serretti, and E. Tempesta Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine Drug and Alcohol Dependence 36 2 1994 139 145
29. E.C. Katz, M.A. Chutuape, H. Jones, D. Jasinski, M. Fingerhood, and M. Stitzer Abstinence incentive effects in a short-term outpatient detoxification program Experimental and Clinical Psychopharmacology 12 2004 262 268
30. N. Lintzeris, J. Bell, G. Bammer, D. Jolley, and L. Rushworth A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal Addiction 97 2002 1395 1404
31. R. Mattick, E. Digiusto, C. Doran, S. O'Brien, M. Shanahan, and J. Kimber National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD): Report of results and recommendations 2001 National Drug and Alcohol Research Centre, UNSW Sydney
32. R.P. Mattick, and W. Hall Are detoxification programmes effective? Lancet 347 1996 97 100
33. C. McGregor, R. Ali, J. White, P. Thomas, and L. Gowing A comparison of agonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: Outcomes at 6 and 12 months Drug and Alcohol Dependence 68 1 2002
34. MIMS Australia MIMS annual 2002: Australian edition 26 ed. 2002 MIMS Australia Sydney
35. M. Raikou, A. Briggs, A. Gray, and A. McGuire Centre-specific or average unit costs in multi-centre studies? Some theory and simulation Health Economics 9 2000 191 198
36. Rawlingsons Australian construction handbook 1999 Rawlhouse Publishing Perth
37. SPSS SPSS release 10.0 (Version 10.0) 2001 SPSS Inc. Chicago
38. A.M. Washton, and R.B. Resnick Clonidine versus methadone for opiate detoxification Lancet 2 8207 1980 1297
39. C. Weisner, J. Mertens, S. Parthasarathy, C. Moore, E. Hunkeler, and T. Hu The outcome and cost of alcohol and drug treatment in an HMO: Day hospital versus traditional outpatient regimens Health Services Research 35 4 2000 791 812